Kyverna Therapeutics, Inc.

KYTX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-091626
Filing date: Mar 4, 2026
Earliest execution date: Feb 24, 2026
Reporting Owners: Miller Andrew Craig (Director)

Summary

Type

Neutral

Net shares

+11,006

% of shares

100.00%

Amount (USD)

$0

Insider confidence score

90.0 out of 100

Positive

  • Massive buy (≥10% of shares)

Negative

  • Minimal buy amount (<$10K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Grant

Date

2026-02-24

Code

A

Net shares

+11,006.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

11,006.0

Derivative Transactions

Transaction 1

Security

Stock Option (right to buy)

Action

Grant

Date

2026-02-24

Code

A

Net shares

+42,945.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

42,945.0

Filing's footnotes

1. Represents a restricted stock unit award of common stock and 1/3rd of the shares underlying the restricted stock unit award shall vest on each one-year anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

2. 1/36th of the shares subject to the option shall vest on each monthly anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.